25 June 2024
TruSpine Technologies
plc
("TruSpine" or the
"Company")
Heads of Terms Agreed for European
Partnership with HD Hospital Device S.R.L.
TruSpine Technologies plc, the medical device
company focused on the spinal (vertebral) stabilisation market is
pleased to announce that it has signed Heads of Terms for a
European partnership with HD Hospital Device S.R.L. ("HD"), a
long-established medical device business in Italy.
The signed Heads of Terms outlines a plan for
TruSpine and HD to work together on research and development,
developing a European business plan to include potential
distribution and manufacturing agreements, subject to agreement on
final commercial terms between TruSpine and HD.
Whilst the Company continues to engage with the
U.S. Food and Drug Administration ("FDA") in relation to its FDA
510(k) application for its Cervi-LOK product, as flagged at the
Company's recent AGM, strategic partnerships are a key part of the
Company's development.
A key element to the strategic partnership
strategy will be working with HD, firstly to seek approval for its
products and then to develop a commercial business plan.
TruSpine
Chairman Geoff Miller commented: "We are excited to have agreed a Heads
of Terms with HD, a European business which can trace its history
back more than 80 years. This agreement is a significant step
forward for the newly restructured TruSpine, and I look forward to
working with HDS management to jointly develop our European
strategy."
HD Director
David Nobili added: "We are happy to
support TruSpine in developing a generation of life and market
changing devices for the good of patients and surgeons."
-END-
Enquiries:
TruSpine Investor Hub
|
https://investorhub.truspinetech.com
|
TruSpine Technologies Plc
|
Tel: +44 (0)20
7118 0852
|
Geoff Miller, Non-executive Chairman
|
|
|
|
Peterhouse Capital Limited (Broker &
Financial Adviser)
|
Tel: +44 (0)20 7469 0930
|
Lucy Williams / Duncan Vasey
|
|
Novus Communications (PR and IR)
|
Tel: +44 (0)1273 704
473
|
Alan Green / Jacqueline Briscoe
|
J.Briscoe@novuscomms.com
|
Caution regarding forward looking
statements
Certain statements in this announcement, are,
or may be deemed to be, forward looking statements. Forward looking
statements are identified by their use of terms and phrases such as
''believe'', ''could'', "should" ''envisage'', ''estimate'',
''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will''
or the negative of those, variations or comparable expressions,
including references to assumptions. These forward-looking
statements are not based on historical facts but rather on the
Directors' current expectations and assumptions regarding the
Company's future growth, results of operations, performance, future
capital and other expenditures (including the amount, nature and
sources of funding thereof), competitive advantages, business
prospects and opportunities. Such forward looking statements reflect
the Directors' current beliefs and assumptions and are based on
information currently available to the Directors.
This communication is a "Reach" announcement.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained in this
announcement is of a non-regulatory nature. Information required to
be notified under the AIM Rules for Companies, Market Abuse
Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on RNS Reach.